首页> 外文期刊>Future Journal of Pharmaceutical Sciences >Synthesis, spectroscopic characterization, X-ray crystallography, structural activity relationship and antimicrobial activity of some novel 4-(5-(10-(3- N, N-dimethylamino)propyl)-10 H-phenothiazine-3-yl)-1, 3, 4-thiadiazole-2-yl) Azo dye/Schiff base derivatives
【24h】

Synthesis, spectroscopic characterization, X-ray crystallography, structural activity relationship and antimicrobial activity of some novel 4-(5-(10-(3- N, N-dimethylamino)propyl)-10 H-phenothiazine-3-yl)-1, 3, 4-thiadiazole-2-yl) Azo dye/Schiff base derivatives

机译:某些新型4-(5-(10-(3- N,N -二甲基氨基)丙基)-的合成,光谱表征,X射线晶体学,结构活性关系和抗菌活性10 H -吩噻嗪-3-基)-1,3,4-噻二唑-2-基)偶氮染料/席夫碱衍生物

获取原文
       

摘要

In the present investigation, a series of novel 4 (5-(10-(3-( N,N -dimethylamino)propyl)-10 H -phenothiazine-3-yl)-1,3,4-thiadiazo-2-yl) Azo dye/Schiff base derivatives (5a-e & 6a-j) were synthesised by performing diazotization followed by coupling reaction between 4-(5-(10-(3-( N,N -dimethylamino)propyl)-10 H -phenothiazine-3yl)-1,3,4-thiadiazole-2-amine, sodium nitrite, Con HCl and the different coupling reagent/condensation reaction of 4-(5-(10-(3-( N,N -dimethylamino)propyl)-10 H -phenothiazine-3yl)-1,3,4-thiadiazole-2-amine and different aromatic aldehyde. The structures of these compounds were confirmed by FT-IR, 1 H NMR, Mass spectroscopy and elemental analysis. In?vitro antibacterial and antifungal activities of these compounds were screened against the different strains such as P.?Aeruginosa (ATCC-2853), E. Coli (ATCC-25922), S. Epidermidis (ATCC-155), A. Fumigatus (ATCC-46645), S. Aureus (ATCC-9144), A. Niger (ATCC-9029) by disc diffusion and minimum inhibitory concentrations (MIC) method. The results revealed that compound N -(4-chlorobenzylidene)-5-(10-(3-( N,N -dimethylamino)propyl)-10 H -phenothiazine-3yl)-1,3,4-thiadiazole-2-amine (6d) showed promising anti-microbial activity against various pathogenic microorganisms as compared to the antibiotics Ciprofloxacin and Fluconazole. Graphical abstract Display Omitted.
机译:在本研究中,一系列新型的4(5-(10-(3-(N,N-二甲基氨基)丙基)-10 H-吩噻嗪-3-基)-1,3,4-噻二唑-2-基)通过重氮化,然后在4-(5-(10-(3-(N,N-二甲基氨基)丙基)-10 H-之间进行偶联反应,合成偶氮染料/席夫碱衍生物(5a-e和6a-j)吩噻嗪-3yl)-1,3,4-噻二唑-2-胺,亚硝酸钠,浓盐酸和4-(5-(10-(3-(N,N-二甲基氨基)丙基)的不同偶联剂/缩合反应)-10 H-吩噻嗪-3yl)-1,3,4-噻二唑-2-胺和不同的芳族醛,通过FT-IR,1 H NMR,质谱和元素分析确认了这些化合物的结构。筛选了这些化合物针对不同菌株的体外抗菌和抗真菌活性,例如铜绿假单胞菌(ATCC-2853),大肠杆菌(ATCC-25922),表皮葡萄球菌(ATCC-155),烟曲霉(ATCC- 46645),金黄色葡萄球菌(ATCC-9144),尼日尔A.尼日尔(ATCC-9029)通过椎间盘扩散和最低抑菌浓度(MIC)方法。结果显示化合物N-(4-氯亚苄基)-5-(10-(3-(N,N-二甲基氨基)丙基)-10 H-吩噻嗪-3yl)-1,3,4-噻二唑-2-胺(6d)与抗生素环丙沙星和氟康唑相比,对各种病原微生物显示出令人鼓舞的抗微生物活性。图形抽象显示被忽略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号